×
0.0541680181641258 0.0217320791436912 0.0217320791436912 -0.0107038598767435 0.0136230943885825 -0.0107038598767435 0.0622770029192345 0.0460590334090172
Stockreport

Immune Pharma inks convertible debt deal at $1.75; shares slump 45% [Seeking Alpha]

IMMUNE PHARMACEUTICALS INC NE (IMNP)  More Company Research Source: Seeking Alpha
Last immune pharmaceuticals inc ne earnings: 11/18 04:08 pm Check Earnings Report
PDF Immune Pharmaceuticals ( IMNP ) enters into an agreement with institutional investors for the sale of $858K aggregate principal amount of convertible debentures. The conversion price will be $1.75 per common share but could drop as low as $1.00 under certain conditions. Net proceeds should be $660K. The company has also lowered the conversion price of an earlier (May 4) convertible debt deal to $1.30 from $2.89 in order to secure investors' support for the new transaction. Yesterday's close was $2.20. Now read: ImmunoCellular down 11% premarket after investor update » [Read more]

IMPACT SNAPSHOT EVENT TIME: IMNP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS